United States v. McKinney

695 F. Supp. 2d 182, 2010 U.S. Dist. LEXIS 24718, 2010 WL 914845
CourtDistrict Court, E.D. Pennsylvania
DecidedMarch 12, 2010
DocketCriminal Action 09-234
StatusPublished
Cited by1 cases

This text of 695 F. Supp. 2d 182 (United States v. McKinney) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. McKinney, 695 F. Supp. 2d 182, 2010 U.S. Dist. LEXIS 24718, 2010 WL 914845 (E.D. Pa. 2010).

Opinion

MEMORANDUM RE: MOTIONS TO SUPPRESS

MICHAEL M. BAYLSON, District Judge.

Defendant in this case has filed two motions to suppress evidence he alleges was unlawfully obtained. Specifically, Defendant seeks to suppress the following: (1) statements he made to law enforcement agents during a search of Defendant’s office on February 5, 2008; (2) statements he made at a Drug Enforcement Agency (“DEA”) Administrative Hearing on April 7, 2008; and (3) physical evidence obtained as a result of a search of Defendant’s office and vehicle on February 5, 2008. After considering Defendant’s suppression motions and the arguments contained therein, the Court denies Defendant’s motions to suppress.

I. Factual and Procedural Background

A. Facts

1. General Case History

Defendant, Dr. Laurence T. McKinney (“Dr. McKinney”), is a physician licensed in Pennsylvania who operated the McKinney Medical Center, a solo practice located at 7514 Frankford Avenue in Philadelphia, Pennsylvania. Dr. McKinney was registered with the DEA, DEA registration number BM7201267, to dispense to patients certain controlled substances. His registration was set to expire on January 31, 2010.

In November 2007, the DEA began receiving complaints from several local pharmacies about receiving an excessive amount of prescriptions for Percocet and Xanax from Dr. McKinney. Also in November 2007, the Philadelphia Police Department received a complaint from an anonymous citizen regarding Dr. McKinney’s prescribing practices. The DEA’s Diversion Unit and the Philadelphia Police Department’s Intensive Drug Investigative Squad (“IDIS”) subsequently launched an investigation into Dr. McKinney’s prescribing practices. During the investigation, numerous surveillances, including audio and video surveillances, were conducted. Also during the investigation, undercover IDIS agents visited Dr. McKinney’s medical office posing as patients in order to acquire prescriptions for *186 controlled substances. 1 These undercover visits were recorded with a “Hawk8A” transmitter/microphone/camera, and DEA and IDIS agents who were positioned across the street from Dr. McKinney’s office during the undercover office visits monitored the audio feed in real-time.

Also during the investigation, DEA obtained a Commonwealth of Pennsylvania Bureau of Narcotics Investigation “BD6 report,” which identified more than 3,000 prescriptions for certain controlled substances dispensed by pharmacies in Pennsylvania on the order or prescription of Dr. McKinney from October 5, 2004 until November 30, 2006. DEA later sought an opinion from an expert, a physician named “Dr. Woodie,” who concluded that Dr. McKinney’s prescribing patterns, as evidenced in the BD6 report, were not consistent with the dispensing of controlled substances for a legitimate medical purpose. Additionally, IDIS agents observed Dr. McKinney and another individual making trips on multiple occasions from Dr. McKinney’s office to his vehicle — a 1997 Mercedes-Benz sedan- — -and placing unidentified items in the vehicle’s glove compartment and trunk, or accessing the trunk area. The agents also observed Dr. McKinney driving from his medical office to local banks during business hours.

As a result of the DEA/IDIS investigation, DEA Diversion Investigator James Corbett (“DI Corbett”) prepared and compiled affidavits for search warrants for Dr. McKinney’s office and vehicle. The search warrants were issued by United States Magistrate Judge Linda K. Caracappa.

2. The Search

On February 5, 2008, shortly after 5:00 p.m., a team of approximately twenty (20) law enforcement officers, including DEA and IDIS agents (the “agents”), executed the search warrants upon Dr. McKinney’s medical office and vehicle. During the search, Dr. McKinney was not handcuffed or restrained in any way, and was not isolated to any particular area of his office. Dr. McKinney was specifically told that he was not under arrest, and he was not read his Miranda rights. (2/4/10 Hearing Audio File # 1 at 21:44-22:00 (Doc. No. 44).) When asked, the agents told Dr. McKinney that he was free to leave at any time, but that the agents preferred he remain in order to observe the search and secure his business and personal belongings that were not the subject of the search. (2/4/10 Hearing Audio File # 1 at 22:36-23:47 (Doc. No. 44).) DI Corbett noted that Dr. McKinney appeared to be under the influence of alcohol or narcotics, as he appeared to be sluggish and drowsy, and was slightly slurring his speech. When asked about this, Dr. McKinney stated that he was not under the influence of alcohol or narcotics, but instead was tired.

At approximately 6:00 p.m., the agents asked Dr. McKinney to voluntarily surrender his DEA Certificate of Registration, which authorized Dr. McKinney to dispense certain controlled substances. Dr. McKinney responded that he wanted to speak with counsel before surrendering his registration, but he was unable to reach counsel via telephone. Directly thereafter, agents served Dr. McKinney with a notice of Immediate Suspension of Registration, which prohibited Dr. McKinney from ordering, administering, prescribing, possessing, or dispensing any controlled substance with his DEA registration.

During the search, Dr. McKinney assisted the agents by identifying patient files *187 that were closed and not covered by the warrant, and by identifying the supplier or distributor of the controlled substances and medications found in his office. At some point during the search, DI Corbett began conversing with and questioning Dr. McKinney. Dr. McKinney eventually told DI Corbett that he no longer wished to speak to him or answer his questions.

Sometime after 9:00 p.m., DI Corbett approached Dr. McKinney and presented him with a target letter informing Dr. McKinney that he was the target of a federal drug investigation. Dr. McKinney again asked if he was being arrested, and DI Corbett responded that Dr. McKinney was not being arrested at that time, although he stated his belief that Dr. McKinney could face criminal charges at some point in the future. DI Corbett and Dr. McKinney then had a conversation which lasted somewhere between thirty (30) and forty-five (45) minutes, in which Dr. McKinney provided information about how he ran his medical practice.

The search concluded at approximately 10:00 p.m. As a result of the office search, the agents seized, among other things, prescription medication, computer equipment, VHS tapes, and thirty-one (31) boxes of medical records. As a result of the vehicle search, the agents seized prescription pills and documents. The agents provided Dr. McKinney with a receipt for items that were seized.

3. DEA Administrative Hearing

On April 7, 2008, Dr. McKinney appeared before Administrative Law Judge (“ALJ”) Mary Ellen Bittner at a DEA Administrative Hearing in Washington, D.C., to address the suspension of Dr. McKinney’s DEA registration. Dr. McKinney was represented at this hearing by Joseph Grimes, Esq. At the hearing, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

People v. Jobi
37 Misc. 3d 954 (New York Supreme Court, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
695 F. Supp. 2d 182, 2010 U.S. Dist. LEXIS 24718, 2010 WL 914845, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-mckinney-paed-2010.